20 May 2016  |  Global
Research and Development Initiatives in Air Conditioners, Diabetes Testing, Touch Sensing Technologies, and Therapy for Liver Diseases - Inside R&D TOE
This edition of the Inside R&D TOE depicts Innovations in air conditioners, diabetes testing, touch sensing technologies, and therapies for liver diseases. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovati...
30 Mar 2016  |  Global
Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory
Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...
01 Jul 2015  |  North America
Constricting Reimbursement Policies Restrain Market Growth
The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...
USD 5,212.50 save 25 %
08 May 2015  |  Global
Genetic Technology Alert. Experimental Genetic Mutation Cuts the Risk of Developing Type 2 Diabetes; Novel Biomarker for Prostate Cancer Identified; Drug Metabolism Test for Epilepsy and Seizure Disorders
This issue profiles experimental genetic mutation that cuts the risk of developing type 2 diabetes, identification of a novel biomarker for prostate cancer, and a drug metabolism test for epilepsy and seizure disorders.
17 Mar 2015  |  Global
Future Options for End Users
The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...
13 Feb 2015  |  Global
Genetic Technology Alert. Promising Gene Therapy for Beta Thalassemia Patients; Nanoparticle Gene Therapy for Brain Tumors; Genetic Predictor Protein for Gestational Diabetes
This issue profiles a promising gene therapy for beta thalassemia patients, a nanoparticle gene therapy for brain tumors, and a genetic predictor protein for gestational diabetes.
28 Apr 2014  |  North America
The marketed and development product landscape for diabetes therapeutics is becoming crowded with multiple products with little differentiation. However, there is still ample room for growth through the introduction of novel therapies that fill therapeutic gaps left by available products. Comprehensive information on market background and global ...
USD 2,962.50 save 25 %
19 Dec 2013  |  Global
Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets
Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...
USD 1,837.50 save 25 %
23 Sep 2013  |  Asia Pacific
Market Opportunities for Differentiated Therapeutics
The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety, but also ensures identity, convenience of handling, and delivery. It needs to balance complex considerations. Pharmaceutical packaging firms are some of the industrys most innovative companies, as has been evident in the last 1...
USD 7,500.00 save 25 %
18 Mar 2013  |  South Asia, Middle East & North Africa
This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...